135 related articles for article (PubMed ID: 1572484)
1. Growth patterns of ovarian follicles during induction of ovulation with decreasing doses of human menopausal gonadotropin following presumed selection in polycystic ovary syndrome.
Schoot DC; Pache TD; Hop WC; de Jong FH; Fauser BC
Fertil Steril; 1992 May; 57(5):1117-20. PubMed ID: 1572484
[TBL] [Abstract][Full Text] [Related]
2. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
Schoot DC; Hop WC; de Jong FH; van Dessel TJ; Fauser BC
Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
[TBL] [Abstract][Full Text] [Related]
3. A study on follicle stimulation and ovulation induction in polycystic ovary syndrome (PCOS).
Ito T; Michioka T; Kobayashi M; Narimatsu A; Yamashita S; Matsuzaki H; Kuramoto T; Numa F; Yakabe A
Horm Res; 1990; 33 Suppl 2():32-4. PubMed ID: 2128879
[TBL] [Abstract][Full Text] [Related]
4. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
Blumenfeld Z; Lang N; Amit A; Kahana L; Yoffe N
Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938
[TBL] [Abstract][Full Text] [Related]
5. Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in patients with polycystic ovary syndrome.
Nakamura Y; Yamada H; Yoshida K; Manno T; Ubukata Y; Suzuki M; Yoshimura Y
Horm Res; 1990; 33 Suppl 2():43-8. PubMed ID: 2128881
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
Tarlatzis BC; Grimbizis G; Pournaropoulos F; Bontis J; Lagos S; Spanos E; Mantalenakis S
Hum Reprod; 1995 Oct; 10(10):2545-9. PubMed ID: 8567767
[TBL] [Abstract][Full Text] [Related]
7. Treatment of polycystic ovarian disease by inducing ovulation with pulsatile subcutaneous administration of human menopausal gonadotrophin associated with luteinizing hormone-releasing hormone analogue.
Nakamura Y; Yoshimura Y; Tamaoka Y; Ubukata Y; Yoshida K; Yamada H; Iizuka R; Suzuki M
Clin Endocrinol (Oxf); 1988 Oct; 29(4):395-402. PubMed ID: 3150824
[TBL] [Abstract][Full Text] [Related]
8. Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist.
Donderwinkel PF; Schoot DC; Pache TD; de Jong FH; Hop WC; Fauser BC
Hum Reprod; 1993 Dec; 8(12):2027-32. PubMed ID: 8150898
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology.
Teissier MP; Chable H; Paulhac S; Aubard Y
Hum Reprod; 1999 Sep; 14(9):2236-41. PubMed ID: 10469686
[TBL] [Abstract][Full Text] [Related]
10. Clomiphene citrate-resistant polycystic ovary syndrome. Preventing multifollicular development.
Ergür AR; Yergök YZ; Ertekin A; Küçük T; Müngen E; Tütüncü L
J Reprod Med; 1998 Mar; 43(3):185-90. PubMed ID: 9564642
[TBL] [Abstract][Full Text] [Related]
11. Ovulation induction in polycystic ovary syndrome with urinary follicle-stimulating hormone or human menopausal gonadotropin.
Seibel MM; McArdle C; Smith D; Taymor ML
Fertil Steril; 1985 May; 43(5):703-8. PubMed ID: 3922800
[TBL] [Abstract][Full Text] [Related]
12. Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease: a new approach to induction of ovulation.
Venturini PL; Remorgida V; Anserini P; De Cecco L
Gynecol Endocrinol; 1988 Sep; 2(3):205-13. PubMed ID: 3147583
[TBL] [Abstract][Full Text] [Related]
13. [Optimal Ovulation Induction in Polycystic Ovary Syndrome Resistant to Clomiphene Citrate or Letrozole.].
Chen Y; Zhang D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):874-877. PubMed ID: 28598116
[TBL] [Abstract][Full Text] [Related]
14. Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in anovulatory infertile women.
Nakamura Y; Yoshimura Y; Tanabe K; Iizuka R
Fertil Steril; 1986 Jul; 46(1):46-54. PubMed ID: 3087790
[TBL] [Abstract][Full Text] [Related]
15. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C
Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819
[TBL] [Abstract][Full Text] [Related]
16. Chronic low-dose follicle-stimulating hormone compared with clomiphene/human menopausal gonadotropin for induction of ovulation.
Yong EL; Ng SC; Chan CL; Kumar J; Teo LS; Ratnam SS
Gynecol Endocrinol; 1997 Feb; 11(1):35-42. PubMed ID: 9086338
[TBL] [Abstract][Full Text] [Related]
17. Use of LHRH agonists in the treatment of anovulation in women with polycystic ovary syndrome.
Franks S; Sagle M; Mason HD; Kiddy D
Horm Res; 1987; 28(2-4):164-8. PubMed ID: 3136067
[TBL] [Abstract][Full Text] [Related]
18. Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study.
Xi W; Liu S; Mao H; Yang Y; Xue X; Lu X
Drug Des Devel Ther; 2015; 9():6001-8. PubMed ID: 26648691
[TBL] [Abstract][Full Text] [Related]
19. Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urofollitropin.
Fridström M; Sjöblom P; Pousette A; Hillensjö T
Eur J Endocrinol; 1997 May; 136(5):488-92. PubMed ID: 9186269
[TBL] [Abstract][Full Text] [Related]
20. A follicular scoring system for monitoring ovulation induction in polycystic ovary syndrome patients based solely on ultrasonographic estimation of follicular development.
Ellenbogen A; Rosenberg R; Shulman A; Libal Y; Anderman S; Jaschevatzky O; Ballas S
Fertil Steril; 1996 Jun; 65(6):1175-7. PubMed ID: 8641493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
